Yuki Gosei Kogyo Co., Ltd.
有機合成薬品工業(株)
2026/07/21 Updated
Market Cap:
$47.4M (¥7.7B)
Stock Price:
$2.19 (¥356)
Exchange Rate: 1 USD = ¥162.34
Stock Price Chart
2026/07/21 Updated24.55
PER (Price Earnings Ratio)
vs Industry Avg: +15.0
0.57
PBR (Price to Book Ratio)
vs Industry Avg: -0.7
2.89%
Dividend Yield
vs Industry Avg: -0.06%
Price Trend
2026/07/21 UpdatedShort-term
5-Day MA
-0.45%
Near-term
25-Day MA
-1.99%
Mid-term
75-Day MA
-1.41%
Long-term
200-Day MA
+1.18%
Price & Trading Details
2026/07/21 UpdatedPRICE
Previous Close
¥346
Open
¥347
High
¥357
Low
¥346
Close
¥356
TRADING
Volume
125,100
Average Volume
185,198
Turnover
¥44,535,600
Min. Purchase
¥35,600
Shareholder Composition
Updated 2026/07/0132.2%
Insider Holdings
7.6%
Institutional
60.2%
Public Float
3
Institutional Holders
Insider Holdings
32.2%
Institutional
7.6%
Public Float
60.2%
Dividend History 4Years Growth
Updated 2026/07/19
-%
Dividend Yield
¥10
Annual Dividend
+11.1%
YoY Growth
-%
Payout Ratio
| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥10 | +11.1% |
| 2025 | ¥9 | +12.5% |
| 2024 | ¥8 | +14.3% |
| 2023 | ¥7 | +75.0% |
| 2022 | ¥4 | - |
Financial Performance
2026/07/19 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥12,839M | ¥12,932M | ¥15,128M | ¥15,448M |
| Gross Profit | ¥3,048M | ¥3,260M | ¥3,307M | ¥2,620M |
| Operating Income | ¥900M | ¥1,128M | ¥1,220M | ¥387M |
| Pretax Income | ¥691M | ¥954M | ¥1,199M | ¥504M |
| Net Income | ¥556M | ¥776M | ¥896M | ¥313M |
| EPS | ¥25.51 | ¥35.57 | ¥41.40 | - |
| Operating Margin | 7.01% | 8.72% | 8.06% | 2.51% |
| Balance Sheet | ||||
| Total Assets | ¥22,118M | ¥24,370M | ¥26,871M | ¥25,730M |
| Total Equity | ¥11,477M | ¥12,429M | ¥13,105M | ¥13,486M |
| Total Liabilities | ¥10,641M | ¥11,941M | ¥13,766M | ¥12,244M |
| Cash | ¥1,143M | ¥588M | ¥973M | ¥885M |
| Interest-bearing Debt | ¥5,581M | ¥6,782M | ¥8,438M | ¥6,745M |
| Equity Ratio | 51.89% | 51.00% | 48.77% | 52.41% |
| D/E Ratio | 0.49 | 0.55 | 0.64 | 0.50 |
| Cash Flow | ||||
| Operating CF | ¥668M | ¥388M | ¥2,143M | ¥2,844M |
| Investing CF | -¥1,237M | -¥1,894M | -¥3,248M | -¥1,008M |
| Financing CF | -¥158M | ¥948M | ¥1,496M | -¥1,922M |
| Free CF | -¥490M | -¥1,367M | -¥1,094M | ¥1,728M |
| Efficiency | ||||
| ROE | 4.84% | 6.24% | 6.84% | 2.32% |
| ROA | 2.51% | 3.18% | 3.33% | 1.22% |
Latest News (5 items)
Company Information
English Name
Yuki Gosei Kogyo Co., Ltd.
Japanese Name
有機合成薬品工業(株)
Stock Code
4531.T (JPX)
Sector / Industry
Basic Materials / Chemicals
Website
https://www.yuki-gosei.co.jp
Employees
296
About
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. The company was incorporated in 1947 and is headquartered in Tokyo, Japan.
Data provided by Yahoo Finance
